Logo - springer
Slogan - springer

Medicine - Oncology & Hematology | Diagnostic and Therapeutic Advances in Hematologic Malignancies

Diagnostic and Therapeutic Advances in Hematologic Malignancies

Tallman, Martin S., Gordon, Leo I. (Eds.)

1999, XIII, 377 p.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$529.00

(net) price for USA

ISBN 978-0-585-38571-6

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$669.00

(net) price for USA

ISBN 978-0-7923-8206-5

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$669.00

(net) price for USA

ISBN 978-1-4757-8267-7

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

There is no field of medicine in which advances in therapy have been so closely linked to a better understanding of molecular medicine than in the area of hematologic malignancies. For example, recent insights into the understanding of Epstein-Barr virus have led to new treatment options for patients with posttransplant lymphoproliferative disorders, as discussed in the chapter by Dr. Richard Ambinder et al. Similarly, Drs. Slack and Gallagher discuss the explosion of recent information regarding the molecular pathogenesis of acute promyelocytic leukemia. This particular morphologic subtype of acute my­ eloid leukemia warrants separate discussion because of our increased under­ standing of the pathogenesis of leukemia, as well as the dramatic advances in outcome that have occurred with differentiation therapy provided by the vitamin A derivative aW-trans retinoic acid, as discussed in the chapter by Drs. Frankel and Powell. New approaches in the therapy of diffuse aggressive lymphomas in relationship to prognostic factors are discussed by Drs. Koc and Schenkein. Novel approaches to cutaneous T-cell lymphomas are discussed by Drs. Foss and Kuzel. Drs. Fonseca and Greipp discuss prognostic factors in myeloma, which are potentially important since they may serve to identify patients who may benefit from aggressive therapy such as bone marrow trans­ plantation, which is discussed in the chapter by Dr. David Vesole. State-of-the-art reviews are provided in the chapters on AIDS-related non- Hodgkin's lymphoma by Drs. Volm and Von Roenn, adult acute lympho­ blastic leukemia by Drs.

Content Level » Research

Keywords » AIDS - bone marrow - cell - classification - leukemia - lymphoma - molecular biology - molecular medicine - stem cell - stem cell transplantation - transplantation - vaccination

Related subjects » Internal Medicine - Oncology & Hematology

Table of contents 

Preface. 1. New Classifications for Non-Hodgkin Lymphoma; W.G. Finn, S.H. Kroft. 2. Epstein-Barr Virus and Lymphoma; R.F. Ambinder, et al. 3. Therapy of Diffuse Aggressive Lymphomas; Y. Koc, D.P. Schenkein. 4. The Molecular Biology of Acute Promyelocytic Leukemia; J.L. Slack, R.E. Gallagher. 5. Current Approaches to Acute Promyelocytic Leukemia; S.R. Frankel, B.L. Powell. 6. Prognosis in Multiple Myeloma; R. Fonseca, P.R. Greipp. 7. Bone Marrow and Stem Cell Transplantation for Multiple Myeloma; D.H. Vesole. 8. Hematopoietic Growth Factors and Acute Leukemia; J.M. Rowe, J.L. Liesveld. 9. Novel Treatment Approaches for Cutaneous T-Cell Lymphoma; F. Foss, T.M. Kuzel. 10. AIDS Associated Lymphoma; M.D. Volm, J.H. von Roenn. 11. Mechanisms of Resistance Against B-Cell Malignancies Induced by Vaccination Against the Immunoglobulin Receptor: The Case for T-Cell Immunity; L.A. Sternas, et al. 12. Novel Biologic Approaches to Hematologic Malignancies; J.P. Dutcher, P.H. Wiernik. 13. Recent Advances in the Biology and Management of Acute Lymphoblastic Leukemia in Adults; O.A. O'Connor, M. Weiss. 14. Advances in the Therapy of the Myelodysplastic Syndromes; P.A. Kouides, J.M. Bennett. Index.

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Oncology.